journal cover

The Potential Therapeutic Capacity of Inhibiting the Brain Renin-Angiotensin System in the Treatment of Co-Morbid Conditions in Epilepsy

CNS Drugs

Nov 3, 2019

Natasha M Ivanova, Jana Dimitrova Tchekalarova

PMID: 31680223

DOI: 10.1007/s40263-019-00678-4

Get paper from

Abstract

Epilepsy is one of the most prevalent neurological diseases and although numerous novel anticonvulsants have been approved, the proportion of patients who are refractory to medical treatment of seizures and have progressive co-morbidities such as cognitive impairment and depression rema...read more

Mentioned in this Paper

Immunologic Adjuvants
Angiotensin II
Anticonvulsants
Brain
Brain Diseases
Cobalt
Complication
Mental Depression
Pharmacotherapy
Epilepsy
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

Drug & Digital Interventions

This feed describes how digital interventions, which are digital and mobile technologies used to support health system needs, can complement and improve pharmacotherapy in disease management. Discover the latest research on drug and digtial intervention here,

Epilepsy

Epilepsy is a chronic neurological disorder characterized by unprovoked and recurrent seizures. Discover the latest research on factors and mechanisms that underlie epilepsy here.

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.

Neurotransmitters

Neurotransmitters are released from synaptic vesicles in presynaptic neurons in response to neural activity, diffuse across the synaptic cleft, and bind specific receptors in order to bring about changes in postsynaptic neurons. Here is the latest research.

ContactHelpTerms Privacy Cookies
© 2019 Meta ULC. All rights reserved

The Potential Therapeutic Capacity of Inhibiting the Brain Renin-Angiotensin System in the Treatment of Co-Morbid Conditions in Epilepsy

CNS Drugs

Nov 3, 2019

Natasha M Ivanova, Jana Dimitrova Tchekalarova

PMID: 31680223

DOI: 10.1007/s40263-019-00678-4

Abstract

Epilepsy is one of the most prevalent neurological diseases and although numerous novel anticonvulsants have been approved, the proportion of patients who are refractory to medical treatment of seizures and have progressive co-morbidities such as cognitive impairment and depression rema...read more

Mentioned in this Paper

Immunologic Adjuvants
Angiotensin II
Anticonvulsants
Brain
Brain Diseases

Similar Papers Found In These Feeds

Related Papers

Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Get paper from

/papers/the-potential-therapeutic-capacity-of-inhibiting/31680223